Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Artivion reported Q3 2026 revenue of $123.8 million, a 9% increase year-over-year, driven by strong performance in On-X and stent grafts. The company narrowed its full-year 2026 revenue guidance to $484-$492 million and is preparing for the U.S. commercial launch of NEXUS in January 2027.
Term
Q3 2026
“In the third quarter of 2026, we delivered 9% constant currency revenue growth, reflecting continued execution of our strategy to drive long-term, profitable growth through an expanding and clinically differentiated product portfolio.”
Pat Mackin, Chairman, President, and Chief Executive Officer
“Overall, we are encouraged by our third quarter performance and the progress we have made so far in 2026. With the recent PMAs of AMDS and NEXUS in the U.S., and ARCEVO LSA on track with enrollment in the ARTIZEN IDE trial, we believe we are on track to being the only company with a comprehensive aortic arch portfolio, which represents an approximately $330 million annual U.S. market opportunity.”
Pat Mackin, Chairman, President, and Chief Executive Officer
StepStone Group reported its second quarter fiscal year 2027 results for the period ended September 30, 2026, and declared a quarterly cash dividend of $0.33 per share. As of the quarter-end, the firm was responsible for approximately $958 billion of total capital, including $261 billion in assets under management. Although filed under Item 2.02, the press release contains only selective operational metrics and lacks a formal GAAP income statement.
OppFi Inc. reported net revenue of $92.8 million for the three months ended September 30, 2026, a decrease from $104.6 million in the prior year period, primarily driven by a larger negative change in the fair value of finance receivables. The company maintained a strong liquidity position with $140.7 million in total cash and restricted cash, while total assets grew to $842.4 million following significant changes in its capital structure and the elimination of noncontrolling interests.
Visa Inc. identifies structural and organizational risks including the integration of acquisitions, the competitive market for AI and cybersecurity talent, and potential voting dilution from the conversion of class B and C common stock. The company also outlines its cybersecurity program, which is integrated into its enterprise risk management framework and aligned with ISO 27002 and PCI DSS standards.
BlackSky Technology Inc. reported a significant revenue increase to $42.8 million for the third quarter of 2026, driven by growth in space-based intelligence and AI services. The company achieved a quarterly net income of $18.5 million, a substantial improvement from the $15.3 million loss in the prior year, largely aided by a $19.7 million gain on derivatives.
Miami International Holdings EVP and CIO Douglas M. Schafer Jr. Sells $1.64M of Stock
Douglas M. Schafer Jr., EVP and CIO, sold 48,000 shares of Miami International Holdings, Inc. at $34.07 to $35.00 a share (average $34.23) in 2 transactions, worth $1.64M in total between Nov 3, 2026 and Nov 4, 2026. Shares held after the trade: 387,414 (-2.0%).
Hanover Insurance Group EVP Willard T. Lee Sells $2.48M of Stock
Willard T. Lee, EVP, sold 9,946 shares of Hanover Insurance Group, Inc. at $248.98 to $249.69 a share (average $249.14) in 2 transactions, worth $2.48M in total on Nov 4, 2026. Shares held after the trade: 6,004 (-27.8%).
Viasat SVP, Pres Viasat Government Craig Andrew Miller Sells $1.58M of Stock
Craig Andrew Miller, SVP, Pres Viasat Government, sold 22,500 shares of Viasat Inc at $70.01 to $70.38 a share (average $70.19) in 2 transactions, worth $1.58M in total on Nov 4, 2026. Shares held after the trade: 41,570 (-20.4%).
Wheeler Real Estate Investment Trust, Inc. reported 1,788,532 common shares outstanding as of November 3, 2026. The company has undergone numerous reverse stock splits in 2025 and 2026 to maintain Nasdaq compliance and manage the dilutive effects of Series D Preferred Stock redemptions and convertible note adjustments.
BRC Group Holdings reported Q3 2026 financial results, including total revenues of $33.0 million and a net loss of $243.0 million, primarily driven by investment losses in Babcock & Wilcox. The company highlighted strategic actions to reduce debt and enhance liquidity, including the sale of its remaining interest in GA Group and a definitive agreement to acquire Sangoma Technologies.
Term
Q3 2026
“Through the first nine months of the year, our operating businesses demonstrated the resilience of our diversified platform, despite third-quarter declines in the value of our investment portfolio. Over the past several months, we have taken key strategic actions to strengthen our core franchises and allocate capital toward our strongest near-term cash flow opportunities.”
Bryant Riley, Chairman and Co-Chief Executive Officer
“Earlier this week, we completed the sale of our remaining interest in GA Group. This legacy business generated significant value for our shareholders over more than a decade, and its sale sharpens our strategic focus, reduces debt, and enhances liquidity, supporting our operating businesses and a long-term approach to our investments through market dislocations.”
Bryant Riley, Chairman and Co-Chief Executive Officer
Celldex Therapeutics reported a net loss of $227.7 million for the first nine months of 2026, driven by increased research and development expenses. The company significantly strengthened its balance sheet through stock issuances, ending the period with $650.3 million in cash, cash equivalents, and marketable securities, which management believes is sufficient to fund operations for at least twelve months.
The Zcash ETF successfully uplisted to NYSE Arca on August 25, 2026, following a 3-for-1 share split. Net assets grew significantly from $200.4 million at year-end 2025 to $875.6 million by September 30, 2026, driven primarily by $377.6 million in unrealized appreciation and $267.8 million in net capital share transactions.
Aflac delivered solid Q3 2026 results driven by significant actuarial assumption unlocks and strategic reinsurance transactions, despite a challenging sales comparison in Japan and cybersecurity-related expenses.
Blend Labs reported third quarter 2026 financial results with revenue of $32.9 million, representing a 1% year-over-year increase. The company achieved its best sales quarter in over three years, closing 26 new deals and expansions, including a new top-10 bank logo and significant momentum for its Autopilot product.
Term
Q3 2026
“We had our best sales quarter in more than three years. Autopilot went from six customers to ten, and the pipeline behind it is now big enough to size. We can’t control the market, but what we can control is converting that pipeline, and that is where the company is focused.”
Baker Hughes Insider John G. Rice Buys $531K of Stock
John G. Rice bought 10,000 shares of Baker Hughes Co at $53.10 a share, worth $531K in total on Nov 3, 2026. Shares held after the trade: 77,315 (+14.9%).
Ategrity Specialty Insurance Company Holdings reported net earned premiums of $346.1 million for the nine months ended September 30, 2026, a significant increase from $258.9 million in the prior year period. Total assets grew to $1.68 billion, while the company maintained a strong capital position with total stockholders' equity of $657.6 million.
General Electric VP Robert M. Giglietti Sells $4.92M of Stock
Robert M. Giglietti, VP, sold 14,796 shares of General Electric Co at $332.12 to $332.69 a share (average $332.54) in 2 transactions, worth $4.92M in total on Nov 4, 2026. Shares held after the trade: 20,201 (-35.3%).
Solventum reported Q3 2026 financial results with net sales of $1.9 billion, a 7.0% decrease primarily due to the impact of advance orders placed in the prior quarter. Despite the sales decline, the company raised its full-year adjusted EPS guidance and reported that its separation from 3M is now more than 90% complete.
Term
Q3 2026
“Solventum delivered third quarter results ahead of our expectations, with every segment contributing, even as we completed our largest ERP cutover; we expect to be near the top end of our full-year organic sales growth range, and are raising our full-year adjusted earnings per share outlook.”
Bryan Hanson, chief executive officer of Solventum
“With separation now more than 90% complete and our growth drivers gaining momentum, we are well positioned to accelerate sales growth and expand margins. We have differentiated innovation, a strong pipeline of new products and a significant opportunity to expand penetration of our existing brands with customers we already serve.”
Bryan Hanson, chief executive officer of Solventum
10x Genomics reported Q3 2026 revenue of $150.7 million, a 1% increase year-over-year, and narrowed its net loss to $19.4 million. The company began commercial shipments of its Atera platform and raised its full-year 2026 revenue guidance to a range of $625 million to $635 million.
Term
Q3 2026
“The biggest highlight of the quarter was the start of commercial shipments of Atera. Enthusiasm for the platform has continued to build, and we are incredibly excited to be putting instruments in customers’ hands. We were also encouraged with the results across our broader business, driven by continued strength in consumables.”
Serge Saxonov, Co-founder and CEO of 10x Genomics
“As biology is entering a new era of AI and data maximalism, 10x is positioned incredibly well to benefit and to be the key enabler of progress going forward.”
For the nine months ended September 30, 2026, Corsair Gaming reported net revenue of $1.04 billion and returned to profitability with a net income of $19.8 million, compared to a net loss of $41.0 million in the prior year period. The company saw a significant improvement in gross profit, which rose to $318.1 million from $281.3 million year-over-year.
Dorchester Minerals, L.P. reported third quarter 2026 net income of $27.6 million, or $0.54 per common unit, on operating revenues of $51.4 million. The results represent a significant increase from the $11.2 million in net income reported in the prior year's third quarter. The partnership also noted its previously declared quarterly distribution of $0.882297 per unit is payable on November 12, 2026.
ARS Pharmaceuticals is focused on the commercialization of neffy, its intranasal epinephrine product, following recent regulatory approvals. The company reported 100,528,400 shares of common stock outstanding as of November 3, 2026, and is classified as a non-accelerated filer and smaller reporting company.
Arlo Technologies reported Q3 2026 financial results featuring record subscriptions and services revenue of $96 million, up 20% year-over-year. The company achieved a GAAP net income of $0.9 million and expanded its non-GAAP gross margin by 760 basis points to 49%. Additionally, Arlo announced a new $100 million share repurchase program authorized through December 2028.
Term
Q3 2026
“Arlo continued its outstanding momentum into the third quarter, delivering 20% growth in subscriptions and services revenue and expanding profitability with adjusted EBITDA up over 50% year over year. And the recent launch of Arlo Secure 7 powered by AI-enabled Threat Assessment keeps Arlo at the forefront of innovation while cementing the foundation for continued growth into the future. Our level of confidence in our future growth opportunities is underscored by the recent authorization of a $100 million share repurchase program.”
Matthew McRae, Chief Executive Officer of Arlo Technologies
Filana Therapeutics reported a net loss of $10.7 million for the third quarter of 2026, with a significant reduction in nine-month operating expenses compared to the prior year. The company received a Nasdaq deficiency notice regarding its share price but maintains a cash position of $78.2 million, which management believes is sufficient for at least the next 12 months.
Health Catalyst reported Q3 2026 financial results, beating the high end of its revenue and Adjusted EBITDA guidance despite a 26% year-over-year revenue decline following the divestiture of its Vitalware business. The company reported GAAP net income of $40.5 million, primarily driven by a $65.9 million gain on the sale of Vitalware, and reaffirmed its full-year 2026 outlook.
Term
3 months
“We delivered a third quarter above the high end of our revenue and Adjusted EBITDA guidance, and we are reaffirming our full-year outlook. Our immediate priority is to strengthen the foundation of the business, with a focus on retaining the clients we serve and developing a path to generating durable, profitable revenue.”
Simeon Kohl, President and Chief Executive Officer
ICF International reported a return to year-on-year revenue growth in Q3 2026, with total revenue increasing 1% to $470 million. While federal and state/local government revenues showed strength, commercial energy revenues underperformed expectations due to regulatory pressures on utilities. The company also declared a quarterly dividend of $0.14 per share payable in January 2027.
Term
Q3 2026
“Our third quarter performance demonstrated the return to year-on-year revenue growth that we anticipated would begin in the second half of this year and benefited from our diversified and integrated business model.”
John Wasson, chair and chief executive officer
“A key highlight of the third quarter was our strong margin performance, benefiting from efficient contract delivery and favorable contract mix. Our Adjusted EBITDA margin was 11.5%, expanding by 10 basis points year-on-year and representing a notable sequential increase.”
Automatic Data Processing Insider Carlos A. Rodriguez Sells $759K of Stock
Carlos A. Rodriguez sold 2,505 shares of Automatic Data Processing Inc at $300.00 to $305.06 a share (average $303.18) in 13 transactions, worth $759K in total on Nov 4, 2026. Shares held after the trade: 20,242 (-2.2%).
The Honest Company reported a significant increase in net income to $91.3 million for Q3 2026, primarily driven by an $89.4 million income tax benefit from the recognition of deferred tax assets. While revenue decreased to $84.6 million from $92.6 million year-over-year, the company improved its gross margin and maintained positive operating income through its 'Transformation Pillars' and 'Powering Honest Growth' initiatives.
For the quarter ended September 30, 2026, IREN reported total revenue of $228 million, a slight decrease from $240 million in the prior year, as growth in AI Cloud revenue was offset by a significant decline in Bitcoin Mining revenue. The company recorded a net loss of $263 million compared to a net income of $385 million in the prior year, primarily driven by higher operating expenses and a large unrealized loss on financial instruments.
Cedar Realty Trust reported total revenues of $20.2 million for the nine months ended September 30, 2026, a decrease from $21.7 million in the prior year period. The company achieved an operating income of $6.7 million for the first nine months of 2026, compared to $3.8 million in 2025, primarily due to the absence of impairment charges recorded in the previous year.